Keywords: OS; oxidative stress; ROS; reactive oxygen species; CNS; central nervous system; PD; Parkinson's disease; AD; Alzheimer's disease; GSH; reduced glutathione; GST; glutathione transferase; GSSG; glutathione disulfide; SN; substantia nigra; BSO; L-buthionine
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ANOVA; analysis of variance; BBB; blood-brain barrier; GDNF; glia-derived neurotrophic factor; GLP-1; glucagon-like peptide 1; MPP+; 1-methyl-4-phenylpyridinium; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; PD; Parkinson's disease; TH; tyrosine
Keywords: DA; dopamine; DHA; docosahexaenoic acid; l-DOPA; levodopa; LID; l-DOPA-induced-dyskinesias; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MRM; Multiple reaction monitoring; PD; Parkinson's disease; Pls; Plasmalogen; PlsEtn; Ethanolamine plasmalogens
Keywords: Mitochondria; Calcium; Metabolism; ATP; mPTP;
Keywords: ADP; adenosine diphosphate; ANT; adenine nucleotide transporter; ATP; adenine triphosphate; C1QBP; complement component 1Q subcomponent-binding protein; Ca2Â +; calcium; CK; creatine kinase; CsA; cyclosporine A; CYCLE; CYCLosporinE A in reperfused acute m
Keywords: DA; dopamine; PD; Parkinson's disease; ADHD; attention-deficit hyperactivity disorder; ASD; autism spectrum disorders; SRY; sex-determining region on the Y chromosome; SNc; substantia nigra pars compacta; SNr; substantia nigra pars reticulata; VTA; ventra
Keywords: Akt; also known as protein kinase B; ANT; adenine nucleotide translocase; Bad; Bcl-2-associated death promoter; Bak; Bcl-2 homologous antagonist/killer; Bax; Bcl-2-like protein 4; Bcl2; B cell lymphoma 2; Bcl-xL; B-cell lymphoma-extra large; Bid; BH3 inte
Keywords: 3-MT; 3-methoxytyramine; 6-OHDA; 6-hydroxydopamine; ANOVA; analysis of variance; DOPAC; 3,4-dihydroxyphenylacetic acid; HPLC; high-performance liquid chromatography; HVA; homovanillic acid; MFB; medial forebrain bundle; MPTP; 1-methyl-4-phenyl-1,2,3,6-tet
Keywords: DAMP; danger-associated molecular pattern; GWAS; genome-wide association studies; IL; interleukin; iNOS; inducible nitric oxide synthase; iTreg; inflammatory suppressing inducible regulatory T cells; LPS; lipopolysaccharide; MHC; major histocompatibility;
Keywords: ANT; adenine nucleotide translocator; BSA; bovine serum albumin; CS; citrate synthase; DCIP; 2,6-dichlorophenolindophenol; DNPH; 2,4-dinitrophenylhydrazine; EGTA; ethylene glycol tetraacetic acid; FW; free wheel voluntary physical activity; Hepes; 4-(2-hy
Keywords: AKT; protein kinase B; BBB; blood-brain barrier; BDNF; brain-derived neurotrophic factor; CNS; central nervous system; DA; dopamine; DAB; diaminobenzidine; 78-DHF; 7,8-dihydroxyflavone; DL; dorsolateral; ECF; enhanced chemifluorescence; EDTA; ethylenedi
Keywords: Dendritic spine; Synaptic plasticity; Neurodegenerative diseases; Psychiatric disorders; Glutamate receptor; Calcium signaling; ADHD; attention deficit hypersensitive disorders; FXS; Fragile X-syndrome; CNS; central nervous system; GABA; gamma amino butyr
Keywords: AD; Alzheimer's disease; ALS; amyotrophic lateral sclerosis; BBB; blood brain barrier; DMAEMA; 2-dimethylaminoethyl methacrylate; HD; Huntington's disease; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MS; multiple sclerosis; 6-OHDA; 6-hydroydopamin
Keywords: AA; ascorbic acid; ALS; amyotrophic lateral sclerosis; BDNF; brain derived neurotropic factor; BMP; bone morphogenetic protein; DNMT; DNA methyltransferase; EB; embryoid body; EBNA1; Epstein-Barr nuclear antigen-1; ERK; extracellular signal-regulated ki
Keywords: ADL; activities of daily living; COMT; catechol-O-methyltransferase; DOI; 2,5-dimethoxy-4-iodoamphetamine; GIRK; G-protein-gated inwardly rectifying potassium; GP; globus pallidus; GPCR; G protein-coupled receptor; GPe; external segment of GP; GPi; intern
Keywords: 6-OHDA; Environmental enrichment; Exercise; MPTP; Mice; Neuroprotection; Neurotrophic factors; Rats
Keywords: Parkinson's disease; Dementia; Attention; 5-arm maze test; MPTP;
Keywords: 5-HT; serotonin; 6-OHDA; 6-hydroxydopamine; BDNF; brain-derived neurotrophic factor; DA; dopamine; EDTA; ethylenediaminetetraacetic acid; FST; forced swimming test; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; OFT; open-field test; p75NTR; pan-neur
Keywords: PD, Parkinson's disease; MEA, microelectrode array; GluOx, glutamate oxidase; AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; TH, tyrosine hydroxylase; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineParkinson's; Cortical; Glutamate; MPTP; M
Keywords: Neuroinflammation; Neurotoxin; Nigrostriatal; Neurodegeneration; Dopaminergic; Microglia; 6-OHDA; MPTP; LPS; Paraquat; Parkinson's disease
Keywords: AceCS2; acetyl-CoA synthetase 2; ADP; adenosine diphosphate; CPS1; carbamoyl phosphate synthetase 1; CPT1; carnitine palmitoyltransferase I; CR; calorie restriction; FOXO3a; forkhead box 03a; GDH; glutamate dehydrogenase; HeLa; human cervical carcinoma ce
Keywords: I/R; ischemia/reperfusion; IPC; ischemia preconditioning; SB21; SB216763; Oli; oligomycin; Atr; atractyloside; ALT; alanine aminotransferase; AST; aspartate aminotransferase; MPTP; mitochondrial permeability transition pore; Akt; protein kinase B; GSK-3;
Keywords: GABAergic; Gamma-amino buytaric acid producing neurons; RNA; ribonucleic acid; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Behavior; Brain; Guppy; Zebrafish; Neurodevelopment;
Keywords: CS2; carbon disulfide; CsA; cyclosporin A; Cytc; Cytochrome c; MPTP; mitochondrial membrane permeability transition pore; ÎΨm; mitochondrial transmembrane potential; ROS; reactive oxygen species; VOCs; volatile organic chemicals; Apoptosis; CS2; Cyclosp
Keywords: Parkinson's disease; 18F-DOPA positron emission tomography; MPTP; Levodopa; Dopaminergic marker;
Keywords: PD; Parkinson's disease; MPP+; 1-methyl-4-phenylpyridinium ion; DAT; dopamine transporter; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; SNpc; substantia nigra pars compacta; DOPAC; 3,4-dihydroxyphenylacetate; HVA; homovanillic acid; ODEs; ordinary
Keywords: ÎΨm; mitochondrial membrane potential; AMI; acute myocardial infarction; CAD; coronary artery disease; Cav-1; caveolin-1; Cav-3; caveolin-3; CPR; cardiopulmonary resuscitation; DHETS; dihydroxyeicosatrienoic acids; DHOMEs; dihydroxyoctadecaenoic acids;
Keywords: AgRP; agouti-related peptide; AIF; apoptosis-inducing factor; AMPK; AMP-activated protein kinase; CaMKII; calcium/calmodulin dependent protein kinase II; Cox6a2; cytochrome c oxidase subunit VI peptide 2a; CPT-1; carnitine palmitoyltransferase 1; ETC; ele
Keywords: Protein tyrosine phosphatase; PTP1B; CD45; CDC25; SHP-1; SHP-2; MPTP; LAR; VHR; Natural products;
Keywords: AKT; protein kinase B; CAV-3; caveolin-3; Cyt c; cytochrome c; eNOS; endothelial nitric oxide synthase; ERK1/2; extracellular signal-regulated kinase 1/2; GRK2; G-protein coupled receptor kinase 2; GSK3β; glycogen synthase kinase 3β; MEK; MAPK/ERK kinas
Keywords: AC; adenylyl cyclase; ALDH; aldehyde dehydrogenase; ANT; adenine nucleotide transporter; AR; adrenergic receptor; ARE; antioxidant response element; ATP; adenosine triphosphate; cAMP; cyclic adenosine monophosphate; COX; cyclo-oxygenase; CsA; cyclosporine
Keywords: Parkinson's disease; MPTP; Non-human primate; Model; Dyskinesia
Keywords: ÎΨm; mitochondrial membrane potential; CCCP; carbonyl cyanide m-chlorophenylhydrazone; DOX; doxorubicin; EDTA; ethylenediaminetetraacetic acid; FHC; ferritin heavy chain; HBSS; Hanks' balanced salt solution; MET; metformin; MPTP; mitochondrial permeab
Keywords: 6-OHDA; 6-hydroxydopamine; CB; calbindin; CNS; central nervous system; CR; calretinin; DA; dopamine; DAB; 3,3â²-Diaminobenzidine; GABA; γ-amino-butyric acid; Gad67; glutamic acid decarboxylase 67; GFAP; glial fibrillary acidic protein; MPTP; 1-methyl-4-
Keywords: ANT; adenine nucleotide translocase; [Ca2+]c; cytosolic calcium concentration; [Ca2+]m; mitochondrial calcium concentration; CsA; cyclosporine A; HK; hexokinase II; H2O2; hydrogen peroxide; IB; intracellular milieu; MCU; mitochondrial Ca2+ uniporter; NCLX
Keywords: 6-OHDA; 6-hydroxydopamine; AMPK; AMP activated protein kinase; cAMP; cyclic adenosine monophosphate; CAT; catalase; CI; complex I; CII; complex II; CIV; complex IV; COX; cytochrome c oxidase; DMSO; dimethyl sulfoxide; DNP; dinitrophenol; DCF; dichlorodihy
Keywords: CL, cardiolipin; Drp1, dynamin-related protein 1; ER, endoplasmic reticulum; GTPase, guanosine triphosphatases; Mfn, mitofusin; MIM, mitochondrial inner membrane; MOM, mitochondrial outer membrane; MOMP, mitochondrial outer membrane permeabilization; MPTP
Keywords: AD; Alzheimer's disease; ALD; X-linked adrenoleukodystrophy; ALDRP; adrenoleukodystrophy-related protein; ALDP; adrenoleukodystrophy protein; ALS; amyotrophic lateral sclerosis; ATF-2; activating transcription factor 2; BBB; blood-brain barrier; AP-1; a
Keywords: Essential tremor; Brain; Genetics; Human population; Mouse models; Pathophysiology; ABA; Allen brain atlas; AβPPswe/PS1ÎE9; amyloid-β protein precursor and presenilin-1; AD; Alzheimer's disease; ALS; amyotrophic lateral sclerosis; ATP; adenosine tri-ph
Keywords: ABR; auditory brainstem responses; AD; Alzheimers disease; ADP; adenosinediphosphate; AGEs; advanced glycation end products; ATP; adenosinetriphosphate; CAPD; chronic ambulatory peritoneal dialysis; CDP-DAG; cytidinediphosphate-diacylglycerol; CFS; chroni
Keywords: Antioxidant gene therapy; Brain ischemia; Neurodegenerative disorders; Oxidative stress; Virus-mediated gene delivery; ROS; ÎΨm; mitochondrial membrane potential; 3-NP; 3-nitropropionic acid; 6-OHDA; 6-hydroxydopamine; AADC; aromatic-l-amino decarboxyla
Keywords: AA; arachidonic acid; ADP; adenosine diphosphate; AIF; apoptosis-inducing factor; AMPK; AMP-activated protein kinase; ANT; adenine nucleotide translocase; Apaf-1; apoptotic protease activating factor-1; ATP; adenosine triphosphate; ATP-ase; ATP synthase;
Keywords: Gases; Neuroprotective effect; Mechanism; Clinical translation; Research perspectives; AD; Alzheimer's disease; AMPA; alpha-amino-d-hydroxy-5-methyl-4-isoxazole-propionate; Ar; argon; ATA; absolute atmosphere; ATP; adenosine triphosphate; BBB; blood-bra
Keywords: ADHD; attention-deficit/hyperactivity disorder; BNST; bed nucleus of the stria terminalis; cAMP; cyclic adenosine monophosphate; DA; dopamine; DAT; dopamine transporter; DOPAC; 3,4-dihydroxyphenylacetic acid; FEO; Food-Entrainable circadian Oscillator; LH
Keywords: Aβ; amyloid-β peptides; APAF-1; apoptotic protease-activating factor-1; E2; 17β-estradiol; ER; estrogen receptor; ERβ; estrogen receptor β; ERE; estrogen responsive elements; HIF-1; hypoxia-inducible factor-1; mPTP; mitochondria permeability transiti
Keywords: ETS; electron transport system; mPTP; mitochondrial permeability transition pore; PmFBs; permeabilized fiber bundles; ROS; reactive oxygen species; TPP; tetraphenylphosponium; Chemotherapy; Mitochondria; Skeletal muscle; Reactive oxygen species; ROS; Meta
Keywords: AA; arachidonic acid; AD; Alzheimer's disease; ANOVA; analysis of variance; DA; dopamine; DAB; 3,3â²-diaminobenzidine; DOPAC; dihydroxyphenylacetic acid; EDTA; ethylenediaminetetraacetic acid; GFAP; glial acidic fibrillary protein; HETE; hydroxyeicosat
Keywords: CARD; caspase activation and recruitment domain; CARDIF; CARD adaptor inducing intereferon-β; CAT; carnitine acyl-CoA transferase; ER; endoplasmic reticulum; FFA; free fatty acid; GSH; reduced glutathione; GSSG; oxidised glutathione; HCC; hepatocellular
Keywords: Akt-GSK3β; Akt-Glycogen Synthase Kinase 3β; ALS; Amyotrophic Lateral Sclerosis; CCCP; Carbonyl cyanide m-chlorophenyl hydrazine; CMT; Charcot-Marie-Tooth; DA; Dopamine; DISC1; Disrupted In Schizophrenia 1; FEZ1; Fasciculation and Elongation Protein-
Keywords: Huntington's disease; Parkinson's disease; Cognition; Review; 6-OHDA; MPTP; Behaviour; Phenotype; Cognitive tests; Basal ganglia; Corticostriatal; Dopamine;